AMEERA-4: a randomized, preoperative window-of-opportunity study of amcenestrant versus letrozole in early breast cancerarticle Published on 2023-11-102024-09-05 Journal: Breast Cancer Research : BCR [Category] update2024, [키워드] Amcenestrant Early breast cancer Ki67 postmenopausal Window-of-opportunity study [DOI] 10.1186/s13058-023-01740-2 PMC 바로가기 [Article Type] article
Association between pharmaceutical modulation of oestrogen in postmenopausal women in Sweden and death due to COVID-19: a cohort study스웨덴 폐경 후 여성에서 에스트로겐의 제약 조절과 COVID-19로 인한 사망의 연관성 : 코호트 연구Epidemiology Published on 2022-01-142022-08-31 Journal: BMJ Open [Category] COVID19(2023년), Fulltext, MERS, SARS, 치료제, [키워드] 95% CI absolute risk adjusted Adjustment age annual income augmentation board Board of Health Breast cancer Charlson Comorbidity Index Cohort cohort study Comorbidity confounder control group COVID-19 death decrease defined diagnosed diagnosed with COVID-19 Endocrine Endocrine Therapy Epidemiology groups highest hormone replacement therapy individual Intervention level of education modulation objective outcome measure participant pharmaceutical positive postmenopausal Primary outcome Public Public Health Agency randomised receiving registries remained replacement therapy Result retrospective risk risk of death sex steroids & HRT significantly Statistics Swedish tested therapy Trial variables Welfare women [DOI] 10.1136/bmjopen-2021-053032 PMC 바로가기 [Article Type] Epidemiology
Detraining Effects on Musculoskeletal Parameters in Early Postmenopausal Osteopenic Women: 3-Month Follow-Up of the Randomized Controlled ACTLIFE StudyOriginal Research Published on 2021-03-122022-10-31 Journal: Calcified Tissue International [Category] COVID-19, [키워드] absence activity aerobic bone mineral density both group control group Controlled COVID-19 pandemic determine detraining Effect Effects Endpoint Exercise intervention extension Follow-up greater high-intensity exercise in both group Lean body mass lock-down period Musculoskeletal outcome parameters performed Period physical activity post-menopausal postmenopausal protocol Randomized reduction Significant significantly Strength and power women [DOI] 10.1007/s00223-021-00829-0 PMC 바로가기 [Article Type] Original Research
Effects of COVID-19 Lockdown on Adherence to Individual Home- or Gym-Based Exercise Training among Women with Postmenopausal OsteoporosisArticle Published on 2021-03-022022-10-30 Journal: International Journal of Environmental Research an [Category] Coronavirus, SARS, [키워드] activities adherence Administered consequence COVID-19 Effect Efficacy events exercise home include individual lockdown log no statistical difference Osteoporosis participant performed physical activity postmenopausal postmenopausal osteoporosis protocol training was recorded women [DOI] 10.3390/ijerph18052441 PMC 바로가기 [Article Type] Article
Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19): a structured summary of a study protocol for a randomized controlled trialCOVID-19(IVERCOR-COVID19) 환자의 입원을 방지하기 위한 Ivermectin: 무작위 대조 시험을 위한 연구 프로토콜의 구조화된 요약Randomized Controlled Trial Published on 2020-11-242022-08-13 Journal: Trials [Category] SARS, 임상, 치료기술, [키워드] 1:1 acute infectious disease addition adherence administration Admission adverse event adverse events age allergy analyzed Anthropometric data antiviral drug antiviral drugs Arm ARMS assessment barrier basal blinded Breastfeeding breastfeeding women Cardiology Care care providers carried cause Chain Reaction childbearing age Chloroquine cirrhosis component components Concomitant Concomitant medication Confirmed connection contraceptive method contraceptives Control control group control groups coordination Corriente COVID-19 COVID-19 patient population criteria current Day death demographic demographic data Diagnosis diagnosis of COVID-19 dialysis discharged dissemination dose double-blind drug Efficacy Efficacy and safety elapsed element EOS Equal example exclusion criteria Final final visit first dose Follow-up greater heart rate Hospitalization hospitalizations Hydroxychloroquine incidence include Inclusion inclusion criteria inclusion/exclusion criteria Informed consent Intervention Invasive mechanical ventilation investigator investigators Ivermectin Ivermectin safety Laboratory less liver Liver cirrhosis Liver disease mal-absorptive syndrome medical history medication menstrual menstrual cycles Mortality negative Negative PCR number objective outcome outcome assessor outcome assessors over oxygen oxygen saturation parallel group participant Participants Participation Patient patients with COVID-19 PCR PCR swab Placebo placebo-controlled study polymerase chain polymerase chain reaction Polymerase chain reaction test postmenopausal pregnant Presence Prevent Primary outcome protocol Public public health randomization Randomized Randomized controlled trial randomly permuted blocks receive recommendation recorded recruitment reducing renal replacement therapy replacement therapy reproductive required Research Sample size SARS-CoV2 secondary severe liver disease single-center standard treatment standard treatment alone Study protocol supplementary material surgical Swab table Tablet temperature the patient Total Treatment Trial Trial registration use of hydroxychloroquine Version Viral viral pathology Vital vital signs vital status web system website weight woman women [DOI] 10.1186/s13063-020-04813-1 PMC 바로가기 [Article Type] Randomized Controlled Trial